/

Other

/

Sandoz

Sandoz

Sandoz

Verified Nov 2026

Other

·

Switzerland flag

Basel, Basel-Stadt

·

Since 1886

Sandoz, headquartered in Basel, Switzerland, manufactures generic medicines and biosimilars for global pharmaceutical markets. Founded in 1886, the company operates with 10,000–50,000 employees and generates over $10 billion in annual revenue. After spinning off from Novartis in 2023, Sandoz became an independent public company serving approximately 500 million patients across 100+ countries, delivering nearly 900 million treatments annually through a portfolio of 1,300–1,500 products.

Sandoz

Verified Nov 2026

AT A GLANCE

Founded

1886

Headquarters

Switzerland flag

Basel, Basel-Stadt

Employees

10,000-50,000

Ownership

Sandoz at a glance

Revenue

$10B+

Est. band

Employees

10,000-50,000

Founded

1886

Headquarters

Basel, Basel-Stadt

Import activity

6013

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

6013

Named foreign suppliers

50

Top origins

Germany · Belgium · India · China

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Sandoz.

What this tells a buyer

Customs records document 6,013 shipments, with primary manufacturing sources in Austria, Slovenia, India, and China, drawing supplies from 21 countries including Germany, Belgium, Italy, and Mexico.

The company produces generics representing 75% of sales and biosimilars comprising 25%, with recent announcements indicating expansion of its biosimilar pipeline and development of recombinant protein therapies.

In mid-2026, Sandoz committed an additional €150 million to its biopharmaceutical manufacturing facility in Toulouse, and signed a landmark agreement with Evotec covering up to 10 biosimilar molecules with potential payments exceeding $650 million.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

140 years in operation (founded 1886).

6,013 US import shipments on record.

Overview

Sandoz, headquartered in Basel, Switzerland, manufactures generic medicines and biosimilars for global pharmaceutical markets. Founded in 1886, the company operates with 10,000–50,000 employees and generates over $10 billion in annual revenue. After spinning off from Novartis in 2023, Sandoz became an independent public company serving approximately 500 million patients across 100+ countries, delivering nearly 900 million treatments annually through a portfolio of 1,300–1,500 products.

At a glance

Attribute

Detail

Founded

1886

Headquarters

Basel, Basel-Stadt

Employees

10,000-50,000

Revenue

$10B+ (estimated)

What Sandoz makes

The company produces generics representing 75% of sales and biosimilars comprising 25%, with recent announcements indicating expansion of its biosimilar pipeline and development of recombinant protein therapies.

Products and capabilities described on the company's own site include Steel (source: sandoz.com).

Trade and customs footprint

Customs records document 6,013 shipments, with primary manufacturing sources in Austria, Slovenia, India, and China, drawing supplies from 21 countries including Germany, Belgium, Italy, and Mexico. US customs bill-of-lading records list 6013 inbound shipments across 50 foreign suppliers, with top origins including Germany · Belgium · India · China.

Latest developments

Company details

In mid-2026, Sandoz committed an additional €150 million to its biopharmaceutical manufacturing facility in Toulouse, and signed a landmark agreement with Evotec covering up to 10 biosimilar molecules with potential payments exceeding $650 million. Sandoz was founded in 1886, has an estimated 10,000-50,000 employees, and is headquartered in Basel, Basel-Stadt. On the LightSource stability read it is rated "Established & active": 140 years in operation (founded 1886). 6,013 US import shipments on record.

Frequently asked questions

What does Sandoz do?

Sandoz, headquartered in Basel, Switzerland, manufactures generic medicines and biosimilars for global pharmaceutical markets. Founded in 1886, the company operates with 10,000–50,000 employees and generates over $10 billion in annual revenue. After spinning off from Novartis in 2023, Sandoz became an independent public company serving approximately 500 million patients across 100+ countries, delivering nearly 900 million treatments annually through a portfolio of 1,300–1,500 products.

Where is Sandoz headquartered?

Sandoz is headquartered in Basel, Basel-Stadt.

When was Sandoz founded?

Sandoz was founded in 1886.

How big is Sandoz?

Sandoz has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).

Does Sandoz import from overseas suppliers?

US customs bill-of-lading records show 6013 inbound shipments for Sandoz, with top origins including Germany · Belgium · India · China.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Basel, Basel-Stadt (HQ)Headquarters · Basel-Stadt, Switzerland
Basel, Basel-Stadt (HQ)Basel, Basel-Stadt, SwitzerlandHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.